PCT检测在全身和局部细菌感染诊断中的临床应用

doi:10.3969/j.issn.1673-8640.2015.01.005

摘要/Abstract

摘要：

目的评价血清降钙素原(PCT)定量检测在全身和局部细菌感染诊断中的临床应用价值。方法采用美国临床实验室标准化协会(CLSI)颁布的EP15-A2文件验证罗氏Cobas E601电化学发光免疫检测系统(简称Cobas E601)检测PCT的精密度和准确度,保证仪器条件符合实验要求。收集全身和局部细菌感染住院患者697例,联合分析患者血培养、痰培养、中段尿培养和脑脊液培养数据及其血清PCT结果,比较全身感染和局部感染及不同部位感染患者血清PCT的变化趋势,并分析革兰阳性球菌和革兰阴性杆菌感染机体PCT的表达差异情况。结果 Cobas E601检测PCT具有良好的重复性,总变异系数(CV)<3.59%,与定值校准品的偏差<5.0%,符合临床检测要求。血清PCT水平在全身和局部感染患者中均升高,且全身感染患者PCT水平明显高于局部感染患者(P<0.05);在局部感染中,呼吸系统、泌尿系统和神经系统感染组间血清PCT水平差异无统计学意义(P>0.05)。在全身感染中,革兰阴性杆菌感染患者血清PCT水平高于革兰阳性球菌感染患者(P<0.05);在局部感染中,此2类细菌感染患者血清PCT水平差异无统计学意义(P>0.05)。结论血清PCT水平在全身感染和局部感染患者样本中均升高,在局部感染中不能通过血清PCT水平鉴别革兰阴性杆菌和革兰阳性球菌的感染。

关键词: 降钙素原, 全身感染, 局部感染, 革兰阴性杆菌, 革兰阳性球菌

Abstract:

Objective To evaluate the clinical application significance of serum procalcitonin(PCT)quantitation determination in the diagnosis of systemic and local bacterial infections. Methods The Clinical and Laboratory Standards Institute (CLSI) EP15-A2 document was employed to verify the precision and accuracy of PCT determination by Roche Cobas E601 chemiluminescence analyzer (Cobas E601) and ensure instrument conditions being complied with the requirement of experiment. A total of 697 patients with systemic and local bacterial infections were enrolled. The results of serum PCT determination, blood culture, sputum culture, middle-urine culture and cerebrospinal culture were used to compare the change trends of serum PCT for systemic and local bacterial infections and for different-part infections. The difference of PCT in Gram-positive cocci and Gram-negative bacilli infections was analyzed. Results Cobas E601 had good repeatability, and the total coefficient of variation (CV) was <3.59%. The fixed calibration bias was <5.0% and met the clinical determination requirements. For serum PCT, there was significance for systemic and local bacterial infections with having increasing serum PCT level(P<0.05). For local bacterial infection, there was no statistical significance for respiratory system, urinary system and nervous system infections (P>0.05). For systemic bacterial infection, there was higher serum PCT level for patients with Gram-negative bacilli infection than with Gram-positive cocci infection (P<0.05). For local bacterial infection, there was no statistical significance for patients with Gram-negative bacilli infection and Gram-positive cocci infection (P>0.05). Conclusions In patients with systemic and local bacterial infections, serum PCT level has high expression, and serum PCT level can not identify local bacterial infection Gram-negative bacilli and Gram-positive cocci infections.

Key words: Procalcitonin, Systemic bacterial infection, Local bacterial infection, Gram-negative bacillus, Gram-positive coccus

中图分类号:

R446.5

慕月晶, 王伟佳, 严海忠, 徐全中, 阚丽娟, 欧阳能良, 黄燕华, 张秀明. PCT检测在全身和局部细菌感染诊断中的临床应用[J]. 检验医学, 2015, 30(1): 17-20.

MU Yuejing, WANG Weijia, YAN Haizhong, XU Quanzhong, KAN Lijuan, OUYANG Nengliang, HUANG Yanhua, ZHANG Xiuming.. The clinical application of PCT in the diagnosis of systemic and local bacterial infections[J]. Laboratory Medicine, 2015, 30(1): 17-20.

图/表 1

参考文献 13

[1]	DANDONA P, NIX D, WILSON MF, et al.Procalcitonin increase after endotoxin injection in normal subjects[J].J Clin Endocrinol Metab,1994,79(6):1605-1608.
[2]	Clinical and Laboratory Standards Institute. User demonstration of performance for precision and accuracy; approved guideline-second edition[S]. EP15-A2, CLSI, 2004.
[3]	National Committee for Clinical Laboratory. User demonstration of performance for precision and accuracy; approved guideline[S]. EP-15A, NCCLS, 2001.
[4]	ASSICOT M, GENDREL D, CARSIN H, et al.High serum procalcitonin concentrations in patients with sepsis and infection[J].Lancet,1993,341(8844):515-518.
[5]	张宗新. 降钙素原在细菌感染性疾病诊断中的应用探讨[J].检验医学,2006,21(2):117-119.
[6]	WANNER GA, KEEL M, STECKHOIZ RU, et al.Relationship between procalciton in plasma and severity of injury, sepsis, organ failure, and mortality in injured patients[J]. Crit Care Med, 2000, 28(4): 950-957.
[7]	WHANG KT, VATH SD, BECKER KL, et al.Procalcitonin and proinflammatory cytokine in interactions in sepsis[J].Shock,1999, 12(4):268-273.Corrected and republished in:Shock,2000,14(1):73-78.
[8]	NYLEN ES, WHANG KT, SNIDER RH, et al.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J]. Cirt Care Med, 1998, 26(6): 1001-1006.
[9]	FENDLER WM, PIOTROWSKI AJ.Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates[J].J Paediatr Child Health,2008,44(3):114-118.
[10]	王凯飞,沈定霞,刘朝军,等.血清降钙素原定量检测与血培养结果的比较[J].中华检验医学杂志,2012,35(3):243-246.
[11]	孙雪东,董金芳,陆地,等.支气管肺泡灌洗液中炎症因子在呼吸机相关性肺炎患者中的动态变化[J].中华医院感染学杂志,2010,20(15):2189-2191.
[12]	杜娟,黄金莲,应巧玲,等.痰液降钙素原检测在儿童社区获得性肺炎中的应用[J].检验医学,2011,26(3):147-149.
[13]	LEVEL C, CHAUVEAU P, GUISSET O, et al.Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure[J]. Crit Care, 2003, 7(6): R160-R166.

项目	均值(ng/mL)	批内标准差(ng/mL)	批内CV(%)	总标准差(ng/mL)	总CV(%)
PC1	0.55	0.01	2.61	0.03	2.94
PC2	10.46	1.24	1.44	1.35	1.55
PC3	0.10	0.01	3.57	0.01	3.59
PC4	0.48	0.01	2.87	0.02	3.09
PC5	56.84	3.49	1.33	4.19	1.93

项目	均值(ng/mL)	批内标准差(ng/mL)	批内CV(%)	总标准差(ng/mL)	总CV(%)
PC1	0.55	0.01	2.61	0.03	2.94
PC2	10.46	1.24	1.44	1.35	1.55
PC3	0.10	0.01	3.57	0.01	3.59
PC4	0.48	0.01	2.87	0.02	3.09
PC5	56.84	3.49	1.33	4.19	1.93

[1]	李莉, 孙海燕, 李媛睿, 窦敏, 汤文, 蒋黎敏, 沈立松. 先天性心脏病患儿围手术期NT-proBNP、 PCT变化及其临床意义[J]. 检验医学, 2023, 38(6): 524-531.
[2]	翟莎娜, 孙清海, 余永武, 叶芳, 刘茂东. 万古霉素联合美罗培南对PDRP患者疗效及血清TNF-α、PCT、IL-6水平和腹膜液WBC计数的影响[J]. 检验医学, 2022, 37(4): 360-364.
[3]	顾峰, 吴艳芬, 赵歆晖, 侯照远, 王志宏, 齐华林. 降钙素原水平与维持性血液透析患者全因死亡的关系[J]. 检验医学, 2022, 37(2): 134-140.
[4]	何学联, 何子翼, 刘月阳, 余炎芝, 张思颖. 基于外周血炎症指标的列线图模型早期诊断新生儿败血症的价值[J]. 检验医学, 2022, 37(10): 921-927.
[5]	李亚周, 马炜, 刘云, 万玉香, 黄晓春, 秦琴. 多指标联合检测在血流感染早期诊断中的价值[J]. 检验医学, 2021, 36(8): 847-850.
[6]	朱传新, 周玉平, 何艳, 周琴. NLR、CRP、PCT、DD、NT-proBNP在重症COVID-19中的诊断价值[J]. 检验医学, 2021, 36(2): 190-193.
[7]	潘锡龙, 徐志远, 谢锋, 李丹. 不同脓毒症诊断标准中降钙素原的临床意义[J]. 检验医学, 2021, 36(12): 1215-1218.
[8]	武静, 于瑞杰. SAA、PCT、PA和CRP在儿童感染性疾病中的价值[J]. 检验医学, 2021, 36(11): 1190-1191.
[9]	朱传新, 周玉平, 周琴, 周桂凤. NLR、PCT、CRP联合检测对早期COVID-19的诊断价值[J]. 检验医学, 2021, 36(1): 53-56.
[10]	赵明海, 李欣, 魏东, 罗敏, 张雅洁, 杨懿祺, 郑磊. 干热法灭活对新型冠状病毒肺炎相关炎症指标检测的影响[J]. 检验医学, 2020, 35(9): 924-927.
[11]	卢秀芬, 贺志军, 刘绮婷, 冯仲信, 马胜. 血清降钙素原和尿液内毒素检测对CAUTI抗菌药物治疗的指导作用[J]. 检验医学, 2020, 35(7): 686-690.
[12]	刘瑞来, 商安全, 关明. HNL、PCT 、TRAIL对血液病患者血流感染的诊断价值[J]. 检验医学, 2020, 35(12): 1277-1280.
[13]	陈星, 张驰, 夏涛. 降钙素原、C反应蛋白、血细胞参数在败血症鉴别诊断中的应用[J]. 检验医学, 2020, 35(12): 1284-1287.
[14]	陈振华, 江琴. 脓毒症患者凝血功能指标、降钙素原水平与临床预后的关系[J]. 检验医学, 2020, 35(10): 1053-1055.
[15]	林文, 黄凯峰, 杨涵, 何春燕, 陈雯静, 舒文, 汤荣, 易峻文, 刘庆中. 泰地唑胺对革兰阳性球菌的体外抗菌活性研究[J]. 检验医学, 2019, 34(5): 428-432.